Form 8-K · Current Report · Filed 2026-08-19
Twist Bioscience Files Prospectus Supplement for Share Resale
Twist Bioscience Corporation has filed a prospectus supplement to register the resale of shares issuable pursuant to a Stock Purchase Agreement with Invenra Inc.
- Filer
- Twist Bioscience Corporation TWST · NASDAQ
- Filed
- Accession
- 0001104659-26-098830
- CIK
- 0001581280
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
The filing includes an opinion from Orrick, Herrington & Sutcliffe LLP as Exhibit 5.1.
Items reported
Reported Item
Market reaction
Close before filing
$116.10
Next session
+17.4%
Since filing
+34.0%
Latest close
$155.56
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from TWST reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, TWST insiders reported 44 Form 4 transactions — net selling of $36.8M.
About Twist Bioscience Corporation
Twist Bioscience Corporation is a synthetic biology and biotechnology company that develops and commercializes DNA-based products built on its proprietary silicon-based synthesis platform. Twist Bioscience Corporation’s core offerings include synthetic genes, DNA oligos, oligo pools, library preparation tools, antibody libraries, and other workflow products used in next-generation sequencing, gene editing, drug discovery, diagnostics, and research. The company serves customers across academic, pharmaceutical, biotech, industrial, and agricultural markets, providing scalable tools for applications that require precise, high-quality synthetic DNA. Its platform supports high-throughput manufacturing and a broad product portfolio that helps researchers and developers design, test, and advance biological innovation across multiple life science segments. Headquartered in South San Francisco, California, Twist Bioscience Corporation plays a specialized role in the global market for synthetic DNA and genomics-enabled research tools.
Never miss another TWST filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.